AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7663312
Drug: ritanserin 10
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ritanserin 10 mg/day
Trial: 630965
Drug: Methylprednisolone (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (two large doses administered intravenously)
Trial: 30739259
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant chemotherapy (PAC) > 3 cycles
Trial: 30739259
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant chemotherapy (PAC) 1-3 cycles
Trial: 27655012
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside (SNP) infusion (0.5 μg/kg per min for 4 h)
Trial: 16669955
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg alicaforsen
Trial: 16669955
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg alicaforsen
Trial: 12783912
Drug: Rofecoxib, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib, 25 mg once daily
Trial: 12783912
Drug: Naproxen, 220
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen, 220 mg twice daily
Trial: 8931866
Drug: PAMBA 100-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAMBA 100-200 mg daily for 7 to 26 days with moderate corticosteroids (mean dose 36.1 mg prednisolone equivalent)
Trial: 8931866
Drug: High-dose corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose corticosteroids (mean 94.2 mg prednisolone equivalent) and immunosuppressive drugs
Trial: 2996580
Drug: Nedocromil (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nedocromil (2 mg) by inhalation
Trial: 31021023
Drug: CSF IL-6
RxNorm normalized name: IL-6
DrugBank: Human interleukin-6 (DB15060)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSF IL-6 concentration >50 pg/ml in neurosarcoidosis patients
Trial: 31021023
Drug: Anti-IL-6 monoclonal
RxNorm normalized name: HUMAN ANTI-IL-6 MONOCLONAL ANTIBODY (PF-04236921)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-IL-6 monoclonal antibody treatment in a refractory neurosarcoidosis patient
Trial: 25972024
Drug: Sustained eradication
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained eradication of Pseudomonas aeruginosa (Pa) after early antipseudomonal therapy
Trial: 25972024
Drug: Nonsustained eradication
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonsustained eradication of Pseudomonas aeruginosa (Pa) after early antipseudomonal therapy
Trial: 18541884
Drug: NGX‐4010 (high-concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NGX‐4010 (high-concentration capsaicin patch)
Trial: 18541884
Drug: Control (low-concentration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (low-concentration capsaicin patch)
Trial: 16028530
Drug: Recombinant IFN‐alpha2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant IFN‐alpha2 with complex immunoglobulin preparation (CIP) via rectal method
Trial: 16028530
Drug: Recombinant IFN‐alpha2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant IFN‐alpha2 with complex immunoglobulin preparation (CIP) via inhalation method
Trial: 12759839
Drug: Heparin coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin coated PMMA intraocular lenses
Trial: 10078608
Drug: Tetanus toxoid
RxNorm normalized name: Tetanus Toxoid
DrugBank: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetanus toxoid (TT) at low concentration (0.1 microg ml(‐1))
Trial: 7672149
Drug: Intracytoplasmic sperm
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracytoplasmic sperm injection with vigorous aspiration of oocyte cytoplasm
Trial: 28841431
Drug: Intensive blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive blood pressure treatment (target SBP: 120 mmHg)
Trial: 28841431
Drug: Standard blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard blood pressure treatment (target SBP: 140 mmHg)
Trial: 24130735
Drug: Non-hypnotic imaginative
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-hypnotic imaginative suggestion
Trial: 18923231
Drug: Celacade therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celacade therapy
Trial: 11925376
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist (multiple low-dose 0.25 mg and single high-dose 3 mg)
Trial: 11925376
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist and GnRH agonist (long protocol)
Trial: 9593172
Drug: WR 238605,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WR 238605, a single oral dose of 600 mg administered 1 day prior to challenge
Trial: 8169182
Drug: Clonazepam (CZP)
RxNorm normalized name: Clonazepam
DrugBank: Clonazepam (DB01068)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonazepam (CZP) up to 2 mg/day for 4 weeks
Trial: 3198992
Drug: Ketanserin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (10 mg IV as bolus)
Trial: 20152561
Drug: Clopidogrel tapering
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel tapering regimen for 4 weeks
Trial: 20152561
Drug: Continued daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continued daily clopidogrel intake for 4 more weeks
Trial: 18953552
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B nasal spray (5 mg/ml)
Trial: 18953552
Drug: Placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nasal spray (lacking amphotericin B)
Trial: 12186600
Drug: Ginkgo, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo, 40 mg 3 times per day (n = 115)
Trial: 897855
Drug: Atropine 0.5
RxNorm normalized name: homatropine 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 0.5 mg injected intramuscularly half an hour before the meal
Trial: 897855
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg injected intramuscularly half an hour before the meal
Trial: 31337342
Drug: Gemcitabine 900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 900 mg/m2 on Days 1 and 8, and docetaxel 70 mg/m2 on Day 8 in 3-week cycles until disease progression or treatment failure.
Trial: 28168925
Drug: Red Bull
RxNorm normalized name: acid red 35
DrugBank: Pantothenic acid (DB01783)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red Bull energy drink 250 mL
Trial: 28168925
Drug: Red Bull
RxNorm normalized name: acid red 35
DrugBank: Pantothenic acid (DB01783)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red Bull Sugarfree energy drink 250 mL
Trial: 28168925
Drug: Placebo 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 250 mL
Trial: 25639864
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy (CCRT) (C arm)
Trial: 12694429
Drug: NK 10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NK 10% gel
Trial: 12694429
Drug: NK 5%
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NK 5% gel
Trial: 1643700
Drug: Intravenous idarubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous idarubicin (12 mg/m2)
Trial: 1643700
Drug: Oral idarubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral idarubicin (30-35 mg/m2)
Trial: 6433636
Drug: Aspirin (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (median dose 31 mg/kg/day)
Trial: 27441478
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose melatonin treatment group (10mg capsule once daily)
Trial: 27441478
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose melatonin treatment group (20mg capsule once daily)
Trial: 16214452
Drug: Highest quintile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highest quintile of magnesium intake (median 433 mg/day)
Trial: 9734735
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of octreotide
Trial: 8295285
Drug: Captopril, 50
RxNorm normalized name: Captopril, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril, 50 mg, twice per day
Trial: 2738792
Drug: Elimination diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elimination diet with double-blind, placebo-controlled oral food challenges
Trial: 1092728
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg indomethacin daily
Trial: 31274533
Drug: Combination intervention
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination intervention of PrEP initiation and retention
Trial: 28689520
Drug: Terlipressin 12-hour
RxNorm normalized name: Terlipressin
DrugBank: Terlipressin (DB02638)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin 12-hour therapy (Group-B)
Trial: 28689520
Drug: Terlipressin 72-hour
RxNorm normalized name: Terlipressin
DrugBank: Terlipressin (DB02638)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin 72-hour therapy (Group-A)
Trial: 17563155
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for anxiety disorders (AD)
Trial: 9625683
Drug: Ursodiol, 300
RxNorm normalized name: Ursodiol, 300 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodiol, 300 mg twice daily (or 300 mg in the morning and 600 mg in the evening if body weight was > 90 kg)
Trial: 1734400
Drug: L-epinephrine
RxNorm normalized name: dl-Epinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-epinephrine
Trial: 7839475
Drug: Dexamethasone (greater
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (greater than 0.6 mg/kg)
Trial: 7839475
Drug: Steroids (when
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids (when intubation is necessary)
Trial: 3203714
Drug: Emthexat 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emthexat 2.5 mg tablets
Trial: 3203714
Drug: Methotrexate 2.5
RxNorm normalized name: methotrexate 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate 2.5 mg tablets
Trial: 2197851
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g protein with 50 g glucose
Trial: 2197851
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g protein with 50 g glucose
Trial: 2197851
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g protein with 50 g glucose
Trial: 2197851
Drug: Various amounts
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various amounts of protein with 50 g glucose
Trial: 30673020
Drug: Diuretics (chlorthalidone/amiloride)
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics (chlorthalidone/amiloride)
Trial: 28431534
Drug: Spirulina platensis
RxNorm normalized name: SPIRULINA PLATENSIS
DrugBank: Spirulina platensis (DB14744)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirulina platensis (500 mg, twice daily)
Trial: 28431534
Drug: Placebo (starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (starch pills, two daily)
Trial: 24940324
Drug: Intravenous diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous diclofenac sodium 75mg
Trial: 21701422
Drug: Systemic EGF
RxNorm normalized name: ABX-EGF
DrugBank: Panitumumab (DB01269)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Systemic EGF treatment initiated immediately after pneumonia onset
Trial: 21701422
Drug: Systemic EGF
RxNorm normalized name: ABX-EGF
DrugBank: Panitumumab (DB01269)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Systemic EGF treatment initiated 24 hours after pneumonia onset
Trial: 17200252
Drug: Heparin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin infusion (0.5 U/kg per hour)
Trial: 9932161
Drug: MTHF (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTHF (100 mg/m2 days 1-5 i.v. bolus) plus FU (400 mg/m2 days 1-5) given as i.v. bolus injection
Trial: 9932161
Drug: MTHF (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTHF (100 mg/m2 days 1-5 i.v. bolus) plus FU (400 mg/m2 days 1-5) given as a two-hour infusion
Trial: 29889748
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg estradiol and 100 mg progesterone
Trial: 29889748
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg estradiol and 100 mg progesterone
Trial: 29889748
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg estradiol and 50 mg progesterone
Trial: 29889748
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg estradiol and 50 mg progesterone
Trial: 26983396
Drug: LM +
RxNorm normalized name: SlowMag Calm + Sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LM + 30 g/day brown milled flaxseed for 12 weeks
Trial: 24731416
Drug: UPPP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UPPP with oral appliance (UA group)
Trial: 22614152
Drug: Enalapril (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (0.1 to 0.30 mg/kg/day)
Trial: 20375709
Drug: H5N1 vaccine
RxNorm normalized name: Influenza H5N1 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H5N1 vaccine (1.9 microg HA/AS03(B), 3.75 microg HA/AS03(B), and 3.75 microg HA/AS03(A))
Trial: 20375709
Drug: H5N1 vaccine
RxNorm normalized name: Influenza H5N1 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H5N1 vaccine
Trial: 17656620
Drug: Vildagliptin 25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 25, 50, 100, and 200 mg
Trial: 17656620
Drug: Vildagliptin 100
RxNorm normalized name: vildagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 100 mg with high-fat meal
Trial: 11824859
Drug: AVP-V1-antagonist (d(CH2)5Tyr(me)AVP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AVP-V1-antagonist (d(CH2)5Tyr(me)AVP; 0.5 mg; AVPi)
Trial: 8678512
Drug: 5-FU alone
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU alone or in combination with chemotherapeutic drugs
Trial: 1855676
Drug: Endoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic injection sclerotherapy using a combination of 1:100,000 adrenaline and 5% ethanolamine
Trial: 1855676
Drug: Endoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic injection sclerotherapy after rebleeding in conservatively treated group
Trial: 6661730
Drug: Cholinergic drugs
RxNorm normalized name: PARASYMPATHOMIMETICS (CHOLINERGICS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinergic drugs (physostigmine, pyridostigmine bromide, edrophonium chloride)
Trial: 6661730
Drug: Anticholinergic drugs
RxNorm normalized name: Anticholinergics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticholinergic drugs (scopolamine, orphenadrine)
Trial: 17684044
Drug: Hormone levels
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone levels measured at baseline and again at 3 and 6 months (total, free, and bioavailable testosterone, dihydrotestosterone, SHBG, LH, dehydroepiandrosterone, dehydroepiandrosterone sulfate, estrone, estradiol, cortisol)
Trial: 15589567
Drug: bupropion (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion (150 mg, PO)
Trial: 15589567
Drug: bupropion (open-label
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion (open-label treatment for 8 weeks)
Trial: 23692553
Drug: Once-daily extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily extended-release topiramate (USL255)
Trial: 21337293
Drug: Pharmaceutical consulting
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pharmaceutical consulting intervention by pharmacists regarding optimized antibiotic therapy
Trial: 21337293
Drug: Pharmaceutical consulting
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pharmaceutical consulting intervention
Trial: 17204956
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg 13C‐urea
Trial: 17204956
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg 13C‐urea
Trial: 9083731
Drug: Conventional sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional sedation (pethidine 25-50 mg and midazolam 2.5 mg)
Trial: 28825227
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy for breast cancer
Trial: 24717951
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) for 12 months
Trial: 19389245
Drug: Focal Psychodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal Psychodynamic Therapy (FPT)
Trial: 12170445
Drug: docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: docetaxel 75 mg/m(2) plus carboplatin to an AUC of 6 every 3 weeks
Trial: 12170445
Drug: vinorelbine 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: vinorelbine 25 mg/m(2) on days 1, 8, 15, and 22 plus cisplatin 100 mg/m(2) on day 1 every 4 weeks
Trial: 9174680
Drug: Intravenous valsartan
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous valsartan (5, 10, and 20 mg)
Trial: 9174680
Drug: Oral valsartan
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral valsartan (80 mg capsule)
Trial: 9174680
Drug: Oral valsartan
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral valsartan (buffered solution, 80 mg)
Trial: 9174680
Drug: Intravenous valsartan
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous valsartan (20 mg)
Trial: 2859199
Drug: Bucindolol 150
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bucindolol 150 mg
Trial: 23019938
Drug: Compound Xuanju
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound Xuanju Capsule (CXC) and Clomiphene Citrate (CC)
Trial: 17901792
Drug: Nonfluoroquinolone antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonfluoroquinolone antibiotics
Trial: 16213381
Drug: Sodium hyaluronate
RxNorm normalized name: sodium hyaluronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium hyaluronate (five weekly intra-articular injections)
Trial: 11825860
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg GHB/kg body wt
Trial: 11825860
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg GHB/kg body wt
Trial: 11825860
Drug: clomethiazole 1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clomethiazole 1000 mg daily (CLO group)
Trial: 10553535
Drug: Gangliosides treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gangliosides treatment (100 mg/day for 15 days followed by 40 mg/day for 75 days)
Trial: 10553535
Drug: Gangliosides treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gangliosides treatment (continuous treatment for 12 months)
Trial: 10553535
Drug: Gangliosides treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gangliosides treatment
Trial: 1869064
Drug: Acetyl-L-carnitine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (30 mg/kg)
Trial: 6132179
Drug: melphalan 6
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: melphalan 6 mg/m2 daily for 5 days every 6 weeks for sixteen cycles
Trial: 6132179
Drug: no additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no additional treatment
Trial: 30684327
Drug: 10 whole-body
RxNorm normalized name: Insects (whole body), mite dermatophagoides farinae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 whole-body cryotherapy treatments associated with 30-minute kinesitherapy
Trial: 15802370
Drug: Phenylephrine (alpha(1)-agonist)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine (alpha(1)-agonist)
Trial: 12375540
Drug: Estrogen cream
RxNorm normalized name: ESTRIOL 4 mg in 85 g / ESTRADIOL 1 mg in 85 g TRANSDERMAL CREAM [BiEST 5.0 Estrogen Cream]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen cream